Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of 132.44 million as of June 13, 2025. Its market cap has decreased by -24.66% in one year.

Market Cap

132.44M

Enterprise Value

90.11M

Revenue

16.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.92

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 132.44M, an increase of 24,863.19%. That is a compound annual growth rate of 34.49%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	132.44M	0.13%
Dec 31, 2024	132.26M	-27.85%
Dec 29, 2023	183.31M	-21.67%
Dec 30, 2022	234.02M	-20.77%
Dec 31, 2021	295.36M	20.59%
Dec 31, 2020	244.93M	-38.25%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	170.36B
Shell	156.00B
HSBC Holdings	150.64B
Unilever	115.47B
British American Tobacco p.l.c.	78.56B
Rolls-Royce Holdings	72.69B
Rio Tinto Group	72.66B
RELX PLC	71.43B

Market Cap Rankings